Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 228

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

MitraClip Therapy in Daily Clinical Practice: Initial Results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry

Open access
Baldus, Stephan, Schillinger, Wolfgang, Franzen, Olaf, Bekeredjian, Raffi, Sievert, Horst, Schofer, Joachim, Kuck, Karl-Heinz, Konorza, Thomas, Möllmann, Helge, Hehrlein, Christoph, Ouarrak, Taoufik, Senges, Jochen, Meinertz, Thomas, for the German Transcatheter Mitral Valve Interventions (TRAMI) investigators · 2012 · European Journal of Heart Failure

Abstract

Aims: A substantial percentage of patients with mitral regurgitation (MR) in need of mitral valve repair are currently considered not suitable for conventional surgery. In Germany, the largest cohort of patients studied to date has been treated using a percutaneous, catheter-based approach. We report the acute outcomes of patients enrolled in the investigator-initiated German transcatheter mitral valve interventions (TRAMI) registry. Methods and results: Between January 2009 and August 2011, 486 patients [median age 75 (interquartile range 70–80) years; 200 women (41%)] were enrolled in the registry (309 retrospectively and 177 prospectively), with 481 patients (99%) having undergone percutaneous edge-to-edge therapy for MR using the MitraClip. At baseline, 93% of patients were in New York Heart Association (NYHA) functional class III or IV and 71% of patients had a left ventricular ejection fraction (LVEF) ≤50%. Two-thirds of patients presented with functional MR. Procedural success was achieved in 94% of patients, with grade III present in 93% of patients at baseline yet only 6% post-intervention. Retrospective patients were followed for a median of 183 days, prospective patients for a median of 44 days. The periprocedural complication rate was low, with only minor bleedings as the most significant event. In-hospital and post-discharge mortality was 2.5% and 12.5%, respectively. Conclusions: Data from the German TRAMI registry suggest that MitraClip therapy is a viable treatment option in daily clinical routine for high surgical risk patients with significant MR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurjhf/hfs079

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 228

Metadata

Authors
Baldus, S., Schillinger, W., Franzen, O., Bekeredjian, R., Sievert, H., Schofer, J., Kuck, K.-H., Konorza, T., Möllmann, H., Hehrlein, C., Ouarrak, T., Senges, J., Meinertz, T., & for the German Transcatheter Mitral Valve Interventions (TRAMI) investigators
Venue
European Journal of Heart Failure
Published
2012-09-01
Volume
14
Issue
9
Pages
1050-1055
ISSN
  • 1388-9842 (ISSN-L)
  • 1879-0844
OpenAlex
W2085850607
Cited by
228
References
2
FWCI
19.57
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MitraClip Therapy in Daily Clinical Practice: Initial Results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry. https://app.cochat.ai/papers/10.1093/eurjhf/hfs079
The paper
Baldus, S., Schillinger, W., Franzen, O., Bekeredjian, R., Sievert, H., Schofer, J., Kuck, K.-H., Konorza, T., Möllmann, H., Hehrlein, C., Ouarrak, T., Senges, J., Meinertz, T., & for the German Transcatheter Mitral Valve Interventions (TRAMI) investigators. (2012). MitraClip Therapy in Daily Clinical Practice: Initial Results from the German Transcatheter Mitral Valve Interventions (TRAMI) Registry. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hfs079

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.